Compounds > angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-
Page last updated: 2024-09-03

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and 2-naphthylamide

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with 2-naphthylamide in 1 studies

Compound Research Comparison

Studies
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)		Trials
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)		Recent Studies (post-2010)
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)		Studies
(2-naphthylamide)		Trials
(2-naphthylamide)		Recent Studies (post-2010) (2-naphthylamide)
31156436118

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carrera-González, Mdel P; Dueñas, B; Martínez-Ferrol, J; Martínez-Martos, JM; Mayas, MD; Ramírez-Expósito, MJ1

Trials

1 trial(s) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and 2-naphthylamide

ArticleYear
Neoadjuvant chemotherapy modifies serum angiotensinase activities in women with breast cancer.
    Maturitas, 2012, Volume: 72, Issue:1

    Topics: Aminopeptidases; Angiotensin II; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Endopeptidases; Female; Glutamyl Aminopeptidase; Humans; Middle Aged; Naphthalenes; Neoadjuvant Therapy; Paclitaxel; Reference Values; Renin-Angiotensin System

2012